BIOGEN INC. — Director's Dealing 2016

Jun 7, 2016

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2016-06-06

Reporting Person: Koppel Adam (EVP, Strategy and Bus. Dev.)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2016-06-06	Common Stock	S	555	$290.00	Disposed	2402.1123	Direct

Footnotes

F1: Sale pursuant to a trading plan intended to comply with Rule 10b5-1 of the Securities Exchange Act of 1934.